SEAPORT THERAPEUTICS INC

SPTX · NASDAQ

Updated at 2026-10-15 09:38:55

$16.68+3.73%
Today's High
$16.97
Today’s Low
$15.78
SEAPORT THERAPEUTICS INC (SPTX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$15.98
Previous Close
$16.68
Volume
208.62K
Market Cap
$892.89M
P/E Ratio
--
EPS
$-1.64

Previous Day Range

$15.78$16.97

52-Week Range

$14.85$28.38

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
101 SEAPORT BLVD., BOSTON, MA, UNITED STATES, 02210-2186
Country
US
Listing Date
2026-05-01
Fiscal Year End
December
Shares Outstanding
53.53M
CIK
--

Seaport Therapeutics, Inc. (SPTX) is a pioneering biopharmaceutical firm dedicated to advancing cutting-edge immune-oncology therapies to meet critical unmet medical needs, particularly in the field of oncology. The company leverages innovative technologies and a robust research pipeline to develop targeted treatment solutions for complex diseases, with a strong focus on cancer. Supported by strategic collaborations and an experienced management team, Seaport Therapeutics is well-positioned to drive scientific advancements that enhance patient outcomes and reshape the landscape of cancer treatment and immunotherapy.

Financial Metrics

Revenue

2026-06-30

--

2026-03-31

$0

2025-03-31

$0

Operating Expenses

2026-06-30

$65.45M

2026-03-31

$27.54M

2025-03-31

$16.18M

Net Income

2026-06-30

-$62.6M

2026-03-31

-$25.4M

2025-03-31

-$13.12M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-03-31

--

Earnings Per Share

2026-06-30

$-1.78

2026-03-31

$-10.34

2025-03-31

--

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$65.45M

2026-03-31

-$27.18M

2025-03-31

-$15.87M

Effective Tax Rate

2026-06-30

-0.02%

2026-03-31

-2.08%

2025-03-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.